Repligen (RGEN) Operating Expenses (2010 - 2026)

Repligen (RGEN) has 17 years of Operating Expenses data on file, last reported at $178.3 million in Q1 2026.

• Quarterly Operating Expenses rose 9.67% year-over-year to $178.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $698.8 million (up 2.36% YoY) and the FY2025 annual result came in at $683.1 million, up 2.02% from the prior year.
• Operating Expenses fell to $178.3 million in Q1 2026 per RGEN's latest filing, from $180.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $204.0 million in Q4 2024 and bottomed at $136.5 million in Q3 2023.
• The 5-year median for Operating Expenses is $153.4 million (2024), against an average of $158.4 million.
• The widest annual swing landed in 2022, when Operating Expenses soared 37.52%; it then decreased 11.76% in 2025.
• Tracing RGEN's Operating Expenses over 5 years: stood at $137.9 million in 2022, then grew by 13.65% to $156.7 million in 2023, then soared by 30.18% to $204.0 million in 2024, then decreased by 11.76% to $180.0 million in 2025, then fell by 0.96% to $178.3 million in 2026.
• Per Business Quant, the three latest RGEN Operating Expenses figures stand at $178.3 million (Q1 2026), $180.0 million (Q4 2025), and $172.0 million (Q3 2025).

Peer Comparison